United Therapeutics Corp. (UTHR)
469.28
-4.14
(-0.87%)
USD |
NASDAQ |
Feb 23, 11:08
United Therapeutics Market Cap : 20.21B for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 3.728B |
| Catalyst Pharmaceuticals, Inc. | 2.938B |
| MannKind Corp. | 1.735B |
| Madrigal Pharmaceuticals, Inc. | 9.854B |
| Vertex Pharmaceuticals, Inc. | 122.42B |
Market Cap Related Metrics
| PE Ratio | 17.79 |
| PS Ratio | 7.234 |
| PEG Ratio | 1.120 |
| Price to Book Value | 3.066 |
| Price to Free Cash Flow | 20.27 |
| Price | 469.28 |
| Earnings Yield | 5.62% |
| PEGY Ratio | 1.120 |
| Operating PE Ratio | 14.93 |
| Normalized PE Ratio | 17.59 |